Volume 17, Number 9—September 2011
Research
Seroepidemiologic Study of Pandemic (H1N1) 2009 during Outbreak in Boarding School, England
Sandra Johnson, Chikwe Ihekweazu
, Pia Hardelid, Nika Raphaely, Katja Hoschler, Alison Bermingham, Muhammad Abid, Richard G. Pebody, Graham Bickler, John T. Watson, and Éamonn O’Moore
, Pia Hardelid, Nika Raphaely, Katja Hoschler, Alison Bermingham, Muhammad Abid, Richard G. Pebody, Graham Bickler, John T. Watson, and Éamonn O’Moore
Table A1
Association of demographic characteristics, self-reported illness variables, and interventions with symptoms of ARI or ILI in boarding school population during outbreak of pandemic (H1N1) 2009, England*
| Demographic characteristics and interventions | No. (%)† with completed questionnaire, n = 695 | No. (%)† with completed questionnaire and matched sample, n = 353 |
|---|---|---|
| Category | ||
| Students | 469 (67.5) | 216 (61.2) |
| Staff |
226 (32.5) |
137 (38.8) |
| Age group, y | ||
| 13–15 | 219 (32.8) | 90 (25.5) |
| 16–18 | 250 (37.5) | 126 (35.7) |
| 20–49 | 111 (16.6) | 71 (20.1) |
| >50 | 87 (13.0) | 66 (18.7) |
| Unknown |
28 |
|
| Sex, staff only† | ||
| Female | 109 (48.2) | 71 (58.8) |
| Male |
117 (51.8) |
66 (48.1) |
| Role, staff only‡ | ||
| Nonteaching | 135 (61.4) | 93 (68.4) |
| Teaching | 85 (38.6) | 43 (31.6) |
| Unknown |
6 |
1 |
| Self-reported illness | ||
| ARI | ||
| No | 424 (64.1) | 199 (58.5) |
| Yes | 237 (35.9) | 141 (41.5) |
| Unknown | 34 | 13 |
| ILI, ARI plus fever | ||
| No | 551 (83.4) | 277 (81.5) |
| Yes | 110 (16.6) | 63 (18.5) |
| Unknown |
34 |
13 |
| Severity§ | ||
| Mild | 145 (62.8) | 81 (57.9) |
| Moderate and severe | 86 (37.2) | 59 (42.1) |
| Unknown |
6 |
1 |
| Duration, d§ | ||
| 1–2 | 26 (14.2) | 14 (13.1) |
| 3–7 | 88 (48.1) | 52 (48.6) |
| 7–10 | 33 (18.0) | 18 (16.8) |
| >10 | 36 (19.7) | 23 (21.5) |
| Unknown |
54 |
34 |
| Interventions | ||
| Took antiviral drugs | ||
| No | 198 (33.5) | 96 (31.7) |
| Yes | 393 (66.5) | 207 (68.3) |
| Unknown | 104 | 50 |
| Use of antiviral drugs: PEP vs. treatment doses | ||
| PEP dose only | 352 (59.6) | 187 (61.7) |
| Treatment dose | 41 (6.9) | 20 (6.6) |
| No information on dose recorded | 104 | 50 |
| Completion of PEP course of antiviral drugs¶ | ||
| No antiviral drugs | 198 (36.5) | 96 (34.3) |
| Course not completed | 51 (9.4) | 25 (8.9) |
| Course completed | 294 (54.1) | 159 (56.8) |
| No information on completion of course provided |
111 |
53 |
| Seasonal influenza vaccine | ||
| No | 216 (33.7) | 105 (31.3) |
| Yes | 425 (66.3) | 230 (68.7) |
| No information recorded | 54 | 18 |
*ARI, acute respiratory infection; ILI, influenza-like illness; PEP, postexposure prophylaxis.
†Percentage of total, excluding those categories in which the response was unknown or blank.
‡All students were male.
§Of those who self-reported ARI: n = 237 with completed questionnaire; n = 141 with completed questionnaire and matched sample.
¶Excluding those who reported taking the treatment dose of antiviral drugs: n = 654 with completed questionnaire; n = 333 with completed questionnaire and matched sample.
Page created: September 06, 2011
Page updated: September 06, 2011
Page reviewed: September 06, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.